Burke Pharmaceuticals Research

Hot Springs, Arkansas 71913

0 studies enrolling now · 1 studies all time

What they study most

BCCs in Gorlin Syndrome Patients

Studies at this site

• CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome — Completed